Global Molecular Diagnostic Market

Molecular Diagnostic Comprehensive Study by Type (Instruments, Reagents, Others), Application (Infectious Disease, Blood Screening, Genetic Testing, Oncology Testing), Technology (PCR, In Situ Hybridization, Chips and Microarrays, Mass Spectrometry, Sequencing, Isothermal Amplification), End User (Hospitals, Reference Laboratories, Others) Players and Region - Global Market Outlook to 2024

Molecular Diagnostic Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Molecular Diagnostic Market Scope
Molecular diagnostics is defined as the collection of techniques which is used to analyze biological markers in the genome as well as proteome. It is used to diagnose and monitor disease and detect risk. It also classifies therapies as per individual patient’s requirement. It also helps in identifying a disease by studying molecules, namely proteins, deoxyribonucleic acid, and ribonucleic acid, in a tissue or fluid. Numerous types of cancer, the upsurge in awareness as well as acceptance of personalized medicines, growth in the biomarker identification are likely to be a prime driver of the global molecular diagnostics market. It is expected to expand at a CAGR of 10.1% from 2018 to 2026

The market study is being classified by Type (Instruments, Reagents and Others), by Application (Infectious Disease, Blood Screening, Genetic Testing and Oncology Testing) and major geographies with country level break-up.

Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Molecular Diagnostic market throughout the predicted period.

Bio-Rad Laboratories, Inc. (United States), Abbott Laboratories (United States), Siemens Healthcare GmbH (Germany), Alere, Inc. (United States), Dako (Denmark), Bayer AG (Germany), Hologic, Inc. (United States), Danaher Corporation. (United States), Sysmex Corporation (Japan) and Novartis AG (Switzerland) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Johnson & Johnson (United States), Qiagen N.V. (Germany), Becton, Dickinson and Company. (United States), Roche Diagnostics (Switzerland), bioMerieux SA (France) and Cepheid (United States).

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Molecular Diagnostic market by Type, Application and Region.

On the basis of geography, the market of Molecular Diagnostic has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Technology, the sub-segment i.e. PCR will boost the Molecular Diagnostic market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Hospitals will boost the Molecular Diagnostic market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Leaders and their expansionary development strategies
On September 2017, the Becton Dickinson and Company (United States) has entered into a distribution agreement with Euroclone (Italy) Company for distribution of molecular tests. This would help in increasing the customer base as well as the expansion of the company, and On November 2015, the Thermo Fisher Scientific (United States) Company has entered into an agreement with Novartis International AG (Switzerland) and Pfizer Inc. (United States) Company in order to develop and commercialize a multi-marker, universal next-generation sequencing (NGS) oncology test. In addition, it will serve as a companion diagnostic (CDx) for non-small cell lung cancer (NSCLC). This strategy has helped in the expansion of the company worldwide.
On March 2018, the QIAGEN (Germany) Company has introduced the GeneReader NGS System, which is designed for any laboratory to deliver actionable results. It would help in the expansion of the product portfolio of the company., and On April 2014, the Merck & Co., Inc., (United States) Company capital arm financed AdvanDx (United States ) Company with more than USD 12 million for research and development of pathogen screening for major hospital-acquired infections. This will, in turn, propel the growth of the molecular diagnostics market in the future.


Market Trend
  • Technology Advancement of the Molecular Diagnostics

Market Drivers
  • Increase in the Prevalence of the Infectious Diseases
  • Increasing Geriatric Population Worldwide
  • High Prevalence of Infectious Diseases and Various Types of Cancers
  • Growth in the Biomarker Identification Market in addition to Advancements in Molecular Techniques

Opportunities
  • Advances in Genomics and Proteomics
  • Growth Opportunities in Emerging Markets such as China, India and others

Restraints
  • Multifaceted Regulatory Frameworks Delaying the Approval of New Molecular Diagnostic Tests

Challenges
  • Dearth of Trained Professionals Limiting the Appropriate Use of New Molecular Diagnostic Technologies
  • Rising Cost of Disease Diagnostics


Key Target Audience
Academic Institutes, Research Institutes, Reference Laboratories, Diagnostics Suppliers, Blood Banks, Home Health Agencies, Market Research and Consulting Firms, Regulatory Bodies, Venture Capitalists, Manufacturers and Distributors of Molecular Diagnostic Instruments and Hospital Laboratories

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase

Report Objectives / Segmentation Covered

By Type
  • Instruments
  • Reagents
  • Others
By Application
  • Infectious Disease
  • Blood Screening
  • Genetic Testing
  • Oncology Testing
By Technology
  • PCR
  • In Situ Hybridization
  • Chips and Microarrays
  • Mass Spectrometry
  • Sequencing
  • Isothermal Amplification

By End User
  • Hospitals
  • Reference Laboratories
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increase in the Prevalence of the Infectious Diseases
      • 3.2.2. Increasing Geriatric Population Worldwide
      • 3.2.3. High Prevalence of Infectious Diseases and Various Types of Cancers
      • 3.2.4. Growth in the Biomarker Identification Market in addition to Advancements in Molecular Techniques
    • 3.3. Market Challenges
      • 3.3.1. Dearth of Trained Professionals Limiting the Appropriate Use of New Molecular Diagnostic Technologies
      • 3.3.2. Rising Cost of Disease Diagnostics
    • 3.4. Market Trends
      • 3.4.1. Technology Advancement of the Molecular Diagnostics
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Molecular Diagnostic, by Type, Application, Technology, End User and Region (value) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Molecular Diagnostic (Value)
      • 5.2.1. Global Molecular Diagnostic by: Type (Value)
        • 5.2.1.1. Instruments
        • 5.2.1.2. Reagents
        • 5.2.1.3. Others
      • 5.2.2. Global Molecular Diagnostic by: Application (Value)
        • 5.2.2.1. Infectious Disease
        • 5.2.2.2. Blood Screening
        • 5.2.2.3. Genetic Testing
        • 5.2.2.4. Oncology Testing
      • 5.2.3. Global Molecular Diagnostic by: Technology (Value)
        • 5.2.3.1. PCR
        • 5.2.3.2. In Situ Hybridization
        • 5.2.3.3. Chips and Microarrays
        • 5.2.3.4. Mass Spectrometry
        • 5.2.3.5. Sequencing
        • 5.2.3.6. Isothermal Amplification
      • 5.2.4. Global Molecular Diagnostic by: End User (Value)
        • 5.2.4.1. Hospitals
        • 5.2.4.2. Reference Laboratories
        • 5.2.4.3. Others
      • 5.2.5. Global Molecular Diagnostic Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Molecular Diagnostic: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Bio-Rad Laboratories, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Abbott Laboratories (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Siemens Healthcare GmbH (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Alere, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Dako (Denmark)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Bayer AG (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Hologic, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Danaher Corporation. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Sysmex Corporation (Japan)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Novartis AG (Switzerland)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Molecular Diagnostic Sale, by Type, Application, Technology, End User and Region (value) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Molecular Diagnostic (Value)
      • 7.2.1. Global Molecular Diagnostic by: Type (Value)
        • 7.2.1.1. Instruments
        • 7.2.1.2. Reagents
        • 7.2.1.3. Others
      • 7.2.2. Global Molecular Diagnostic by: Application (Value)
        • 7.2.2.1. Infectious Disease
        • 7.2.2.2. Blood Screening
        • 7.2.2.3. Genetic Testing
        • 7.2.2.4. Oncology Testing
      • 7.2.3. Global Molecular Diagnostic by: Technology (Value)
        • 7.2.3.1. PCR
        • 7.2.3.2. In Situ Hybridization
        • 7.2.3.3. Chips and Microarrays
        • 7.2.3.4. Mass Spectrometry
        • 7.2.3.5. Sequencing
        • 7.2.3.6. Isothermal Amplification
      • 7.2.4. Global Molecular Diagnostic by: End User (Value)
        • 7.2.4.1. Hospitals
        • 7.2.4.2. Reference Laboratories
        • 7.2.4.3. Others
      • 7.2.5. Global Molecular Diagnostic Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Molecular Diagnostic: by Type(USD Million)
  • Table 2. Molecular Diagnostic Instruments , by Region USD Million (2013-2018)
  • Table 3. Molecular Diagnostic Reagents , by Region USD Million (2013-2018)
  • Table 4. Molecular Diagnostic Others , by Region USD Million (2013-2018)
  • Table 5. Molecular Diagnostic: by Application(USD Million)
  • Table 6. Molecular Diagnostic Infectious Disease , by Region USD Million (2013-2018)
  • Table 7. Molecular Diagnostic Blood Screening , by Region USD Million (2013-2018)
  • Table 8. Molecular Diagnostic Genetic Testing , by Region USD Million (2013-2018)
  • Table 9. Molecular Diagnostic Oncology Testing , by Region USD Million (2013-2018)
  • Table 10. Molecular Diagnostic: by Technology(USD Million)
  • Table 11. Molecular Diagnostic PCR , by Region USD Million (2013-2018)
  • Table 12. Molecular Diagnostic In Situ Hybridization , by Region USD Million (2013-2018)
  • Table 13. Molecular Diagnostic Chips and Microarrays , by Region USD Million (2013-2018)
  • Table 14. Molecular Diagnostic Mass Spectrometry , by Region USD Million (2013-2018)
  • Table 15. Molecular Diagnostic Sequencing , by Region USD Million (2013-2018)
  • Table 16. Molecular Diagnostic Isothermal Amplification , by Region USD Million (2013-2018)
  • Table 17. Molecular Diagnostic: by End User(USD Million)
  • Table 18. Molecular Diagnostic Hospitals , by Region USD Million (2013-2018)
  • Table 19. Molecular Diagnostic Reference Laboratories , by Region USD Million (2013-2018)
  • Table 20. Molecular Diagnostic Others , by Region USD Million (2013-2018)
  • Table 21. South America Molecular Diagnostic, by Country USD Million (2013-2018)
  • Table 22. South America Molecular Diagnostic, by Type USD Million (2013-2018)
  • Table 23. South America Molecular Diagnostic, by Application USD Million (2013-2018)
  • Table 24. South America Molecular Diagnostic, by Technology USD Million (2013-2018)
  • Table 25. South America Molecular Diagnostic, by End User USD Million (2013-2018)
  • Table 26. Brazil Molecular Diagnostic, by Type USD Million (2013-2018)
  • Table 27. Brazil Molecular Diagnostic, by Application USD Million (2013-2018)
  • Table 28. Brazil Molecular Diagnostic, by Technology USD Million (2013-2018)
  • Table 29. Brazil Molecular Diagnostic, by End User USD Million (2013-2018)
  • Table 30. Argentina Molecular Diagnostic, by Type USD Million (2013-2018)
  • Table 31. Argentina Molecular Diagnostic, by Application USD Million (2013-2018)
  • Table 32. Argentina Molecular Diagnostic, by Technology USD Million (2013-2018)
  • Table 33. Argentina Molecular Diagnostic, by End User USD Million (2013-2018)
  • Table 34. Rest of South America Molecular Diagnostic, by Type USD Million (2013-2018)
  • Table 35. Rest of South America Molecular Diagnostic, by Application USD Million (2013-2018)
  • Table 36. Rest of South America Molecular Diagnostic, by Technology USD Million (2013-2018)
  • Table 37. Rest of South America Molecular Diagnostic, by End User USD Million (2013-2018)
  • Table 38. Asia Pacific Molecular Diagnostic, by Country USD Million (2013-2018)
  • Table 39. Asia Pacific Molecular Diagnostic, by Type USD Million (2013-2018)
  • Table 40. Asia Pacific Molecular Diagnostic, by Application USD Million (2013-2018)
  • Table 41. Asia Pacific Molecular Diagnostic, by Technology USD Million (2013-2018)
  • Table 42. Asia Pacific Molecular Diagnostic, by End User USD Million (2013-2018)
  • Table 43. China Molecular Diagnostic, by Type USD Million (2013-2018)
  • Table 44. China Molecular Diagnostic, by Application USD Million (2013-2018)
  • Table 45. China Molecular Diagnostic, by Technology USD Million (2013-2018)
  • Table 46. China Molecular Diagnostic, by End User USD Million (2013-2018)
  • Table 47. Japan Molecular Diagnostic, by Type USD Million (2013-2018)
  • Table 48. Japan Molecular Diagnostic, by Application USD Million (2013-2018)
  • Table 49. Japan Molecular Diagnostic, by Technology USD Million (2013-2018)
  • Table 50. Japan Molecular Diagnostic, by End User USD Million (2013-2018)
  • Table 51. India Molecular Diagnostic, by Type USD Million (2013-2018)
  • Table 52. India Molecular Diagnostic, by Application USD Million (2013-2018)
  • Table 53. India Molecular Diagnostic, by Technology USD Million (2013-2018)
  • Table 54. India Molecular Diagnostic, by End User USD Million (2013-2018)
  • Table 55. South Korea Molecular Diagnostic, by Type USD Million (2013-2018)
  • Table 56. South Korea Molecular Diagnostic, by Application USD Million (2013-2018)
  • Table 57. South Korea Molecular Diagnostic, by Technology USD Million (2013-2018)
  • Table 58. South Korea Molecular Diagnostic, by End User USD Million (2013-2018)
  • Table 59. Taiwan Molecular Diagnostic, by Type USD Million (2013-2018)
  • Table 60. Taiwan Molecular Diagnostic, by Application USD Million (2013-2018)
  • Table 61. Taiwan Molecular Diagnostic, by Technology USD Million (2013-2018)
  • Table 62. Taiwan Molecular Diagnostic, by End User USD Million (2013-2018)
  • Table 63. Australia Molecular Diagnostic, by Type USD Million (2013-2018)
  • Table 64. Australia Molecular Diagnostic, by Application USD Million (2013-2018)
  • Table 65. Australia Molecular Diagnostic, by Technology USD Million (2013-2018)
  • Table 66. Australia Molecular Diagnostic, by End User USD Million (2013-2018)
  • Table 67. Rest of Asia-Pacific Molecular Diagnostic, by Type USD Million (2013-2018)
  • Table 68. Rest of Asia-Pacific Molecular Diagnostic, by Application USD Million (2013-2018)
  • Table 69. Rest of Asia-Pacific Molecular Diagnostic, by Technology USD Million (2013-2018)
  • Table 70. Rest of Asia-Pacific Molecular Diagnostic, by End User USD Million (2013-2018)
  • Table 71. Europe Molecular Diagnostic, by Country USD Million (2013-2018)
  • Table 72. Europe Molecular Diagnostic, by Type USD Million (2013-2018)
  • Table 73. Europe Molecular Diagnostic, by Application USD Million (2013-2018)
  • Table 74. Europe Molecular Diagnostic, by Technology USD Million (2013-2018)
  • Table 75. Europe Molecular Diagnostic, by End User USD Million (2013-2018)
  • Table 76. Germany Molecular Diagnostic, by Type USD Million (2013-2018)
  • Table 77. Germany Molecular Diagnostic, by Application USD Million (2013-2018)
  • Table 78. Germany Molecular Diagnostic, by Technology USD Million (2013-2018)
  • Table 79. Germany Molecular Diagnostic, by End User USD Million (2013-2018)
  • Table 80. France Molecular Diagnostic, by Type USD Million (2013-2018)
  • Table 81. France Molecular Diagnostic, by Application USD Million (2013-2018)
  • Table 82. France Molecular Diagnostic, by Technology USD Million (2013-2018)
  • Table 83. France Molecular Diagnostic, by End User USD Million (2013-2018)
  • Table 84. Italy Molecular Diagnostic, by Type USD Million (2013-2018)
  • Table 85. Italy Molecular Diagnostic, by Application USD Million (2013-2018)
  • Table 86. Italy Molecular Diagnostic, by Technology USD Million (2013-2018)
  • Table 87. Italy Molecular Diagnostic, by End User USD Million (2013-2018)
  • Table 88. United Kingdom Molecular Diagnostic, by Type USD Million (2013-2018)
  • Table 89. United Kingdom Molecular Diagnostic, by Application USD Million (2013-2018)
  • Table 90. United Kingdom Molecular Diagnostic, by Technology USD Million (2013-2018)
  • Table 91. United Kingdom Molecular Diagnostic, by End User USD Million (2013-2018)
  • Table 92. Netherlands Molecular Diagnostic, by Type USD Million (2013-2018)
  • Table 93. Netherlands Molecular Diagnostic, by Application USD Million (2013-2018)
  • Table 94. Netherlands Molecular Diagnostic, by Technology USD Million (2013-2018)
  • Table 95. Netherlands Molecular Diagnostic, by End User USD Million (2013-2018)
  • Table 96. Rest of Europe Molecular Diagnostic, by Type USD Million (2013-2018)
  • Table 97. Rest of Europe Molecular Diagnostic, by Application USD Million (2013-2018)
  • Table 98. Rest of Europe Molecular Diagnostic, by Technology USD Million (2013-2018)
  • Table 99. Rest of Europe Molecular Diagnostic, by End User USD Million (2013-2018)
  • Table 100. MEA Molecular Diagnostic, by Country USD Million (2013-2018)
  • Table 101. MEA Molecular Diagnostic, by Type USD Million (2013-2018)
  • Table 102. MEA Molecular Diagnostic, by Application USD Million (2013-2018)
  • Table 103. MEA Molecular Diagnostic, by Technology USD Million (2013-2018)
  • Table 104. MEA Molecular Diagnostic, by End User USD Million (2013-2018)
  • Table 105. Middle East Molecular Diagnostic, by Type USD Million (2013-2018)
  • Table 106. Middle East Molecular Diagnostic, by Application USD Million (2013-2018)
  • Table 107. Middle East Molecular Diagnostic, by Technology USD Million (2013-2018)
  • Table 108. Middle East Molecular Diagnostic, by End User USD Million (2013-2018)
  • Table 109. Africa Molecular Diagnostic, by Type USD Million (2013-2018)
  • Table 110. Africa Molecular Diagnostic, by Application USD Million (2013-2018)
  • Table 111. Africa Molecular Diagnostic, by Technology USD Million (2013-2018)
  • Table 112. Africa Molecular Diagnostic, by End User USD Million (2013-2018)
  • Table 113. North America Molecular Diagnostic, by Country USD Million (2013-2018)
  • Table 114. North America Molecular Diagnostic, by Type USD Million (2013-2018)
  • Table 115. North America Molecular Diagnostic, by Application USD Million (2013-2018)
  • Table 116. North America Molecular Diagnostic, by Technology USD Million (2013-2018)
  • Table 117. North America Molecular Diagnostic, by End User USD Million (2013-2018)
  • Table 118. United States Molecular Diagnostic, by Type USD Million (2013-2018)
  • Table 119. United States Molecular Diagnostic, by Application USD Million (2013-2018)
  • Table 120. United States Molecular Diagnostic, by Technology USD Million (2013-2018)
  • Table 121. United States Molecular Diagnostic, by End User USD Million (2013-2018)
  • Table 122. Canada Molecular Diagnostic, by Type USD Million (2013-2018)
  • Table 123. Canada Molecular Diagnostic, by Application USD Million (2013-2018)
  • Table 124. Canada Molecular Diagnostic, by Technology USD Million (2013-2018)
  • Table 125. Canada Molecular Diagnostic, by End User USD Million (2013-2018)
  • Table 126. Mexico Molecular Diagnostic, by Type USD Million (2013-2018)
  • Table 127. Mexico Molecular Diagnostic, by Application USD Million (2013-2018)
  • Table 128. Mexico Molecular Diagnostic, by Technology USD Million (2013-2018)
  • Table 129. Mexico Molecular Diagnostic, by End User USD Million (2013-2018)
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Molecular Diagnostic: by Type(USD Million)
  • Table 141. Molecular Diagnostic Instruments , by Region USD Million (2019-2024)
  • Table 142. Molecular Diagnostic Reagents , by Region USD Million (2019-2024)
  • Table 143. Molecular Diagnostic Others , by Region USD Million (2019-2024)
  • Table 144. Molecular Diagnostic: by Application(USD Million)
  • Table 145. Molecular Diagnostic Infectious Disease , by Region USD Million (2019-2024)
  • Table 146. Molecular Diagnostic Blood Screening , by Region USD Million (2019-2024)
  • Table 147. Molecular Diagnostic Genetic Testing , by Region USD Million (2019-2024)
  • Table 148. Molecular Diagnostic Oncology Testing , by Region USD Million (2019-2024)
  • Table 149. Molecular Diagnostic: by Technology(USD Million)
  • Table 150. Molecular Diagnostic PCR , by Region USD Million (2019-2024)
  • Table 151. Molecular Diagnostic In Situ Hybridization , by Region USD Million (2019-2024)
  • Table 152. Molecular Diagnostic Chips and Microarrays , by Region USD Million (2019-2024)
  • Table 153. Molecular Diagnostic Mass Spectrometry , by Region USD Million (2019-2024)
  • Table 154. Molecular Diagnostic Sequencing , by Region USD Million (2019-2024)
  • Table 155. Molecular Diagnostic Isothermal Amplification , by Region USD Million (2019-2024)
  • Table 156. Molecular Diagnostic: by End User(USD Million)
  • Table 157. Molecular Diagnostic Hospitals , by Region USD Million (2019-2024)
  • Table 158. Molecular Diagnostic Reference Laboratories , by Region USD Million (2019-2024)
  • Table 159. Molecular Diagnostic Others , by Region USD Million (2019-2024)
  • Table 160. South America Molecular Diagnostic, by Country USD Million (2019-2024)
  • Table 161. South America Molecular Diagnostic, by Type USD Million (2019-2024)
  • Table 162. South America Molecular Diagnostic, by Application USD Million (2019-2024)
  • Table 163. South America Molecular Diagnostic, by Technology USD Million (2019-2024)
  • Table 164. South America Molecular Diagnostic, by End User USD Million (2019-2024)
  • Table 165. Brazil Molecular Diagnostic, by Type USD Million (2019-2024)
  • Table 166. Brazil Molecular Diagnostic, by Application USD Million (2019-2024)
  • Table 167. Brazil Molecular Diagnostic, by Technology USD Million (2019-2024)
  • Table 168. Brazil Molecular Diagnostic, by End User USD Million (2019-2024)
  • Table 169. Argentina Molecular Diagnostic, by Type USD Million (2019-2024)
  • Table 170. Argentina Molecular Diagnostic, by Application USD Million (2019-2024)
  • Table 171. Argentina Molecular Diagnostic, by Technology USD Million (2019-2024)
  • Table 172. Argentina Molecular Diagnostic, by End User USD Million (2019-2024)
  • Table 173. Rest of South America Molecular Diagnostic, by Type USD Million (2019-2024)
  • Table 174. Rest of South America Molecular Diagnostic, by Application USD Million (2019-2024)
  • Table 175. Rest of South America Molecular Diagnostic, by Technology USD Million (2019-2024)
  • Table 176. Rest of South America Molecular Diagnostic, by End User USD Million (2019-2024)
  • Table 177. Asia Pacific Molecular Diagnostic, by Country USD Million (2019-2024)
  • Table 178. Asia Pacific Molecular Diagnostic, by Type USD Million (2019-2024)
  • Table 179. Asia Pacific Molecular Diagnostic, by Application USD Million (2019-2024)
  • Table 180. Asia Pacific Molecular Diagnostic, by Technology USD Million (2019-2024)
  • Table 181. Asia Pacific Molecular Diagnostic, by End User USD Million (2019-2024)
  • Table 182. China Molecular Diagnostic, by Type USD Million (2019-2024)
  • Table 183. China Molecular Diagnostic, by Application USD Million (2019-2024)
  • Table 184. China Molecular Diagnostic, by Technology USD Million (2019-2024)
  • Table 185. China Molecular Diagnostic, by End User USD Million (2019-2024)
  • Table 186. Japan Molecular Diagnostic, by Type USD Million (2019-2024)
  • Table 187. Japan Molecular Diagnostic, by Application USD Million (2019-2024)
  • Table 188. Japan Molecular Diagnostic, by Technology USD Million (2019-2024)
  • Table 189. Japan Molecular Diagnostic, by End User USD Million (2019-2024)
  • Table 190. India Molecular Diagnostic, by Type USD Million (2019-2024)
  • Table 191. India Molecular Diagnostic, by Application USD Million (2019-2024)
  • Table 192. India Molecular Diagnostic, by Technology USD Million (2019-2024)
  • Table 193. India Molecular Diagnostic, by End User USD Million (2019-2024)
  • Table 194. South Korea Molecular Diagnostic, by Type USD Million (2019-2024)
  • Table 195. South Korea Molecular Diagnostic, by Application USD Million (2019-2024)
  • Table 196. South Korea Molecular Diagnostic, by Technology USD Million (2019-2024)
  • Table 197. South Korea Molecular Diagnostic, by End User USD Million (2019-2024)
  • Table 198. Taiwan Molecular Diagnostic, by Type USD Million (2019-2024)
  • Table 199. Taiwan Molecular Diagnostic, by Application USD Million (2019-2024)
  • Table 200. Taiwan Molecular Diagnostic, by Technology USD Million (2019-2024)
  • Table 201. Taiwan Molecular Diagnostic, by End User USD Million (2019-2024)
  • Table 202. Australia Molecular Diagnostic, by Type USD Million (2019-2024)
  • Table 203. Australia Molecular Diagnostic, by Application USD Million (2019-2024)
  • Table 204. Australia Molecular Diagnostic, by Technology USD Million (2019-2024)
  • Table 205. Australia Molecular Diagnostic, by End User USD Million (2019-2024)
  • Table 206. Rest of Asia-Pacific Molecular Diagnostic, by Type USD Million (2019-2024)
  • Table 207. Rest of Asia-Pacific Molecular Diagnostic, by Application USD Million (2019-2024)
  • Table 208. Rest of Asia-Pacific Molecular Diagnostic, by Technology USD Million (2019-2024)
  • Table 209. Rest of Asia-Pacific Molecular Diagnostic, by End User USD Million (2019-2024)
  • Table 210. Europe Molecular Diagnostic, by Country USD Million (2019-2024)
  • Table 211. Europe Molecular Diagnostic, by Type USD Million (2019-2024)
  • Table 212. Europe Molecular Diagnostic, by Application USD Million (2019-2024)
  • Table 213. Europe Molecular Diagnostic, by Technology USD Million (2019-2024)
  • Table 214. Europe Molecular Diagnostic, by End User USD Million (2019-2024)
  • Table 215. Germany Molecular Diagnostic, by Type USD Million (2019-2024)
  • Table 216. Germany Molecular Diagnostic, by Application USD Million (2019-2024)
  • Table 217. Germany Molecular Diagnostic, by Technology USD Million (2019-2024)
  • Table 218. Germany Molecular Diagnostic, by End User USD Million (2019-2024)
  • Table 219. France Molecular Diagnostic, by Type USD Million (2019-2024)
  • Table 220. France Molecular Diagnostic, by Application USD Million (2019-2024)
  • Table 221. France Molecular Diagnostic, by Technology USD Million (2019-2024)
  • Table 222. France Molecular Diagnostic, by End User USD Million (2019-2024)
  • Table 223. Italy Molecular Diagnostic, by Type USD Million (2019-2024)
  • Table 224. Italy Molecular Diagnostic, by Application USD Million (2019-2024)
  • Table 225. Italy Molecular Diagnostic, by Technology USD Million (2019-2024)
  • Table 226. Italy Molecular Diagnostic, by End User USD Million (2019-2024)
  • Table 227. United Kingdom Molecular Diagnostic, by Type USD Million (2019-2024)
  • Table 228. United Kingdom Molecular Diagnostic, by Application USD Million (2019-2024)
  • Table 229. United Kingdom Molecular Diagnostic, by Technology USD Million (2019-2024)
  • Table 230. United Kingdom Molecular Diagnostic, by End User USD Million (2019-2024)
  • Table 231. Netherlands Molecular Diagnostic, by Type USD Million (2019-2024)
  • Table 232. Netherlands Molecular Diagnostic, by Application USD Million (2019-2024)
  • Table 233. Netherlands Molecular Diagnostic, by Technology USD Million (2019-2024)
  • Table 234. Netherlands Molecular Diagnostic, by End User USD Million (2019-2024)
  • Table 235. Rest of Europe Molecular Diagnostic, by Type USD Million (2019-2024)
  • Table 236. Rest of Europe Molecular Diagnostic, by Application USD Million (2019-2024)
  • Table 237. Rest of Europe Molecular Diagnostic, by Technology USD Million (2019-2024)
  • Table 238. Rest of Europe Molecular Diagnostic, by End User USD Million (2019-2024)
  • Table 239. MEA Molecular Diagnostic, by Country USD Million (2019-2024)
  • Table 240. MEA Molecular Diagnostic, by Type USD Million (2019-2024)
  • Table 241. MEA Molecular Diagnostic, by Application USD Million (2019-2024)
  • Table 242. MEA Molecular Diagnostic, by Technology USD Million (2019-2024)
  • Table 243. MEA Molecular Diagnostic, by End User USD Million (2019-2024)
  • Table 244. Middle East Molecular Diagnostic, by Type USD Million (2019-2024)
  • Table 245. Middle East Molecular Diagnostic, by Application USD Million (2019-2024)
  • Table 246. Middle East Molecular Diagnostic, by Technology USD Million (2019-2024)
  • Table 247. Middle East Molecular Diagnostic, by End User USD Million (2019-2024)
  • Table 248. Africa Molecular Diagnostic, by Type USD Million (2019-2024)
  • Table 249. Africa Molecular Diagnostic, by Application USD Million (2019-2024)
  • Table 250. Africa Molecular Diagnostic, by Technology USD Million (2019-2024)
  • Table 251. Africa Molecular Diagnostic, by End User USD Million (2019-2024)
  • Table 252. North America Molecular Diagnostic, by Country USD Million (2019-2024)
  • Table 253. North America Molecular Diagnostic, by Type USD Million (2019-2024)
  • Table 254. North America Molecular Diagnostic, by Application USD Million (2019-2024)
  • Table 255. North America Molecular Diagnostic, by Technology USD Million (2019-2024)
  • Table 256. North America Molecular Diagnostic, by End User USD Million (2019-2024)
  • Table 257. United States Molecular Diagnostic, by Type USD Million (2019-2024)
  • Table 258. United States Molecular Diagnostic, by Application USD Million (2019-2024)
  • Table 259. United States Molecular Diagnostic, by Technology USD Million (2019-2024)
  • Table 260. United States Molecular Diagnostic, by End User USD Million (2019-2024)
  • Table 261. Canada Molecular Diagnostic, by Type USD Million (2019-2024)
  • Table 262. Canada Molecular Diagnostic, by Application USD Million (2019-2024)
  • Table 263. Canada Molecular Diagnostic, by Technology USD Million (2019-2024)
  • Table 264. Canada Molecular Diagnostic, by End User USD Million (2019-2024)
  • Table 265. Mexico Molecular Diagnostic, by Type USD Million (2019-2024)
  • Table 266. Mexico Molecular Diagnostic, by Application USD Million (2019-2024)
  • Table 267. Mexico Molecular Diagnostic, by Technology USD Million (2019-2024)
  • Table 268. Mexico Molecular Diagnostic, by End User USD Million (2019-2024)
  • Table 269. Research Programs/Design for This Report
  • Table 270. Key Data Information from Secondary Sources
  • Table 271. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Molecular Diagnostic: by Type USD Million (2013-2018)
  • Figure 5. Global Molecular Diagnostic: by Application USD Million (2013-2018)
  • Figure 6. Global Molecular Diagnostic: by Technology USD Million (2013-2018)
  • Figure 7. Global Molecular Diagnostic: by End User USD Million (2013-2018)
  • Figure 8. South America Molecular Diagnostic Share (%), by Country
  • Figure 9. Asia Pacific Molecular Diagnostic Share (%), by Country
  • Figure 10. Europe Molecular Diagnostic Share (%), by Country
  • Figure 11. MEA Molecular Diagnostic Share (%), by Country
  • Figure 12. North America Molecular Diagnostic Share (%), by Country
  • Figure 13. Global Molecular Diagnostic share by Players 2018 (%)
  • Figure 14. Global Molecular Diagnostic share by Players (Top 3) 2018(%)
  • Figure 15. Global Molecular Diagnostic share by Players (Top 5) 2018(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Bio-Rad Laboratories, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 18. Bio-Rad Laboratories, Inc. (United States) Revenue: by Geography 2018
  • Figure 19. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 20. Abbott Laboratories (United States) Revenue: by Geography 2018
  • Figure 21. Siemens Healthcare GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 22. Siemens Healthcare GmbH (Germany) Revenue: by Geography 2018
  • Figure 23. Alere, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 24. Alere, Inc. (United States) Revenue: by Geography 2018
  • Figure 25. Dako (Denmark) Revenue, Net Income and Gross profit
  • Figure 26. Dako (Denmark) Revenue: by Geography 2018
  • Figure 27. Bayer AG (Germany) Revenue, Net Income and Gross profit
  • Figure 28. Bayer AG (Germany) Revenue: by Geography 2018
  • Figure 29. Hologic, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 30. Hologic, Inc. (United States) Revenue: by Geography 2018
  • Figure 31. Danaher Corporation. (United States) Revenue, Net Income and Gross profit
  • Figure 32. Danaher Corporation. (United States) Revenue: by Geography 2018
  • Figure 33. Sysmex Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 34. Sysmex Corporation (Japan) Revenue: by Geography 2018
  • Figure 35. Novartis AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 36. Novartis AG (Switzerland) Revenue: by Geography 2018
  • Figure 37. Global Molecular Diagnostic: by Type USD Million (2019-2024)
  • Figure 38. Global Molecular Diagnostic: by Application USD Million (2019-2024)
  • Figure 39. Global Molecular Diagnostic: by Technology USD Million (2019-2024)
  • Figure 40. Global Molecular Diagnostic: by End User USD Million (2019-2024)
  • Figure 41. South America Molecular Diagnostic Share (%), by Country
  • Figure 42. Asia Pacific Molecular Diagnostic Share (%), by Country
  • Figure 43. Europe Molecular Diagnostic Share (%), by Country
  • Figure 44. MEA Molecular Diagnostic Share (%), by Country
  • Figure 45. North America Molecular Diagnostic Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Bio-Rad Laboratories, Inc. (United States)
  • Abbott Laboratories (United States)
  • Siemens Healthcare GmbH (Germany)
  • Alere, Inc. (United States)
  • Dako (Denmark)
  • Bayer AG (Germany)
  • Hologic, Inc. (United States)
  • Danaher Corporation. (United States)
  • Sysmex Corporation (Japan)
  • Novartis AG (Switzerland)
Additional players considered in the study are as follows:
Johnson & Johnson (United States) , Qiagen N.V. (Germany) , Becton, Dickinson and Company. (United States) , Roche Diagnostics (Switzerland) , bioMerieux SA (France) , Cepheid (United States) ,
Select User Access Type

Key Highlights of Report


Apr 2019 230 Pages 68 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Molecular Diagnostic Market Quantitative research analysis
Global Molecular Diagnostic Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Know More About Global Molecular Diagnostic Market Report?

Have a Query? Click Here

Other Related Reports

Sciatica Treatment Comprehensive Study by Type (L4 Nerve Root Sciatica, L5 Nerve Root Sciatica, S1 Nerve Root Sciatica, Others), Drugs (Anesthetics, Pain killers, Muscle relaxants, Antidepressants, S...
$ 3750
Rhytidectomy Comprehensive Study by Type (Drugs (Antiscarring, Dressings and Compression Support, Sealant), Sutures, Others), Application (Hospitals, Clinics), Type (Full Facelift, Mid Facelift (Uppe...
$ 3650
MicroRNA Consumables Comprehensive Study by Type (Instruments, Consumables), Application (Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease, Others), E...
$ 3800
Fenofibric Acid Comprehensive Study by Type (45 mg Delayed Release Capsules, 135 mg Delayed Release Capsules), Application (Hospital, Drug store) Players and Region - Global Market Outlook to 2030
$ 3500
Molecular Diagnostics Comprehensive Study by Type (Instruments, Reagents, Software & Services), Application (Infectious Diseases (HIV, HPV, Tuberculosis and Other Infectious Diseases), Oncology (Brea...
$ 3750
Thyroid Function Tests Comprehensive Study by Type (TSH Tests (Thyroid Stimulating Hormone Test), FT4 Tests (Free T4), FT3 Tests (Free T3)), End User (Hospitals, Diagnostic Laboratories, Research Lab...
$ 3350